| Year |
Citation |
Score |
| 2022 |
Tsao AS, Wistuba I, Xia D, Byers L, Diao L, Wang J, Papadimitrakopoulou V, Tang X, Lu W, Kadara H, Grigoryev DN, Selvan ME, Gümüş ZH, Tan Z, Zhang S, et al. Germline and Somatic Smoothened Mutations in Non-Small-Cell Lung Cancer Are Potentially Responsive to Hedgehog Inhibitor Vismodegib. Jco Precision Oncology. 1: 1-10. PMID 35172522 DOI: 10.1200/PO.17.00149 |
0.309 |
|
| 2016 |
Elamin Y, Xia D, Gold KA, Byers LA, Fan YH, Diao L, Wang J, Giri U, Gudikote J, Tran HT, Heymach J. Reprogramming of cell signaling in response to MEK inhibition in non-small cell cancer (NSCLC). Journal of Clinical Oncology. 34: e23222-e23222. DOI: 10.1200/jco.2016.34.15_suppl.e23222 |
0.406 |
|
| 2014 |
Xia D, Byers LA, Diao L, Wang J, Lin SH, Gibbons DL, Gold KA, Paul J, Liu N, Heymach JV. Abstract 3702: Integrated genomic and proteomic analysis identifies PTEN loss and AKT/MTOR as drivers of resistance to MEK inhibitors in NSCLC cells Cancer Research. 74: 3702-3702. DOI: 10.1158/1538-7445.Am2014-3702 |
0.521 |
|
| 2010 |
Kim SH, Xia D, Kim SW, Holla V, Menter DG, Dubois RN. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Research. 70: 4054-63. PMID 20442290 DOI: 10.1158/0008-5472.Can-09-2110 |
0.34 |
|
| 2010 |
Xia D, Holla VR, Wang D, Menter DG, DuBois RN. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Research. 70: 824-31. PMID 20068165 DOI: 10.1158/0008-5472.Can-09-2105 |
0.46 |
|
| 2010 |
Xia D, Wang D, Menter DG, DuBois RN. Abstract B39: Prostaglandin E2 induces human enhancer of filamentation 1 to promote the cell motility of colorectal carcinoma cells Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B39 |
0.474 |
|
| 2010 |
Xia D, Menter DG, DuBois RN. Abstract 5298: Human enhancer of filamentation 1 induction by Prostaglandin E2 enhances the cell motility of colorectal cancer cells Cancer Research. 70: 5298-5298. DOI: 10.1158/1538-7445.Am10-5298 |
0.447 |
|
| 2007 |
Sethi G, Kwang SA, Xia D, Kurie JM, Aggarwal BB. Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the down-regulation of NF-κB activation and NF-κB-regulated antiapoptotic gene products Journal of Immunology. 179: 1926-1933. PMID 17641059 DOI: 10.4049/Jimmunol.179.3.1926 |
0.543 |
|
| 2007 |
Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, Wistuba II, Aggarwal BB, Kurie JM. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. The Journal of Biological Chemistry. 282: 3507-19. PMID 17158870 DOI: 10.1074/Jbc.M610141200 |
0.65 |
|
| 2006 |
Srinivas H, Xia D, Moore NL, Uray IP, Kim H, Ma L, Weigel NL, Brown PH, Kurie JM. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. The Biochemical Journal. 395: 653-62. PMID 16417524 DOI: 10.1042/Bj20051794 |
0.577 |
|
| 2003 |
Lee HY, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM. Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival. The Journal of Biological Chemistry. 278: 23630-8. PMID 12714585 DOI: 10.1074/Jbc.M300997200 |
0.607 |
|
| Show low-probability matches. |